Advantages of organ-sparing treatment approaches in metastatic kidney cancer.
Iurii VitrukOleg VoylenkoOleksandr StakhovskyOleksii KononenkoMaksym PikulSofiya SemkoBohdan HrechkoDenis KoshelEduard StakhovskyPublished in: Journal of cancer research and clinical oncology (2022)
Partial nephrectomy is a safe method of choice in patients with metastatic ccRCC. Kidney preservation in a metastatic setting can play a role in reducing potential adverse systemic therapy events and in decreasing the risk for concomitant pathology deterioration.